Prevail Therapeutics Inc. - 74140Y101

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q4 2020 · Q3 2020
Value (USD)
Total reported value ($000)
$514.8M
QoQ value delta ($000)
+$256.7M (+99.45%)
Implied price effect (QoQ)
+126.12%
Shares
Total shares
22,367,072
QoQ shares delta
-2,990,398 (-11.79%)
Total shares held by funds (by quarter)

Top holders (Q4 2020)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
ORBIMED ADVISORS LLC 318,884 13,822,463 2.79%
CITADEL ADVISORS LLC 55,776 2,417,690 0.01%
VANGUARD GROUP INC 19,266 835,120 0.0%
MILLENNIUM MANAGEMENT LLC 15,819 685,687 0.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 13,842 600,000 0.03%
Alyeska Investment Group, L.P. 13,739 595,553 7.85%
BANK OF AMERICA CORP /DE/ 12,502 541,875 0.0%
GOLDMAN SACHS GROUP INC 6,771 293,489 0.0%
BALYASNY ASSET MANAGEMENT LLC 6,399 277,374 0.04%
Polar Asset Management Partners Inc. 6,159 266,960 0.07%
STATE STREET CORP 5,547 240,454 0.0%
Man Group plc 4,614 200,000 0.02%
GABELLI FUNDS LLC 4,186 181,442 0.03%
GEODE CAPITAL MANAGEMENT, LLC 3,632 157,464 0.0%
NORTHERN TRUST CORP 3,588 155,511 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 3,520 152,576 0.0%
Weiss Asset Management LP 2,603 112,827 0.11%
Qube Research & Technologies Ltd 2,458 106,544 0.03%
LMR Partners LLP 1,846 80,000 0.03%
Altshuler Shaham Ltd 1,198 51,933 0.02%
Squarepoint Ops LLC 1,002 43,430 0.01%
Bank of New York Mellon Corp 773 33,526 0.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 768 33,282 0.0%
WELLS FARGO & COMPANY/MN 755 83,679 0.0%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 745 32,305 0.0%